Diagnosis of nontuberculous mycobacterial infections

Clinics in Laboratory Medicine

Volumn 22, Issue 4, 2002, Pages 911-925

  Brown Elliott, Barbara A ^a   Griffith, David E ^a   Wallace Jr , Richard J ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; CULTURE MEDIUM; DNA SEQUENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LABORATORY DIAGNOSIS; MOLECULAR DYNAMICS; MYCOBACTERIOSIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; REVIEW; THIN LAYER CHROMATOGRAPHY; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM;

CULTURE MEDIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 1842847361     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(02)00018-5     Document Type: Review

References (42)

1. Brown-Elliott BA, Griffith DE, Wallace RJ, Jr. Newly described or emerging human species of nontuberculous mycobacteria. Infect Dis Clin N Amer 2002;16:187-220.
2. Metchock BG, Nolte FS, Wallace RJ Jr. Mycobacterium. In: Murray PR, editor. Manual of Clinical Microbiology. 7th Edition. Washington, DC: American Society for Microbiology; 1999. p. 399-437.
3. Kent PT, Kubica GP. Public Health Mycobacteriology: A Guide for the Level III Laboratory. Centers for Disease Control. Atlanta, GA: US Department of Health and Human Services; 1985.
4. Wayne LG, Kubica GP. Mycobacteria. In: Sneath PHA, editor. Bergey's Manual of Systematic Bacteriology, Volume 2. Baltimore (MD): Williams & Williams; 1986. p. 1435-57.
5. Wolinsky E. State of the art: Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979;119:107-59.
6. Wright PW, Wallace RJ Jr., Wright NW, Brown BA, Griffith DE. Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus non-tuberculous mycobacteria. J Clin Microbiol 1998;36:1046-9.
7. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardia and Other Aerobic Actinomycetes. 2nd Edition. Wayne (PA): Tentative Standard; 2000.
8. Wallace RJ Jr, Glassroth J, Griffith DE, et al. Supplement: American Thoracic Society: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156(Suppl):S1-25.
9. Jost KC, Dunbar DF, Barth SS, Headley VL, Elliott LB. Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models. J Clin Microbiol 1995;33:1270-7.
10. LeBrun L, Espinasse F, Poveda JD, Vincent-Levy-Frebault V. Evaluation of nonradioactive DNA probes for identification of mycobacteria. J Clin Microbiol 1992;30:2476-8.
11. Tortoli E, Simonetti MT, Lavinia F. Evaluation of reformulated chemiluminescent DNA probe (AccuProbe) for culture identification of mycobacterium kansasii. J Clin Microbiol 1996;34:2838-40.
12. Goto M, Oka S, Okuzumi K, Kimura S, Shimada K. Evaluation of acridiniumester-labeled DNA probes for identification of Mycobacterium tuberculosis and Mycobacterium avium-Mycobacterium intracellulare complex in culture. J Clin Microbiol 1991;29:2473-6.
13. Chapin-Robertson K, Dahlberg S, Waycott S, Corrales J, Kontnick C, Edberg SC. Detection and identification of Mycobacterium directly from BACTEC bottles by using a DNA-rRNA probe. Diagn Microbiol Infect Dis 1993;17:203-7.
14. Somoskövi Á, Hotaling JE, Fitzgerald M, et al. False-positive results for Mycobacterium celatum with the AccuProbe Mycobacterium tuberculosis complex assay. J Clin Microbiol 2000;38:2743-5.
15. Park H, Jang H, Kim C, et al. Detection and identification of mycobacteria by amplification of the internal transcribed spacer regions with genus- and species-specific PCR primers. J Clin Microbiol 2000;38:4080-5.
16. Plikaytis BB, Plikaytis BD, Yakrus MA, et al. Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol 1992;30:1815-22.
17. Telenti A, Marchesi F, Balz M, Bally F, Böttger EC, Bodmer T. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol 1993;31:175-8.
18. Steingrube VA, Gibson JL, Brown BA, et al. PCR amplification and restriction endonuclease analysis of a 65-Kilodalton heat shock protein gene sequence for taxonomic separation of rapidly growing mycobacteria. J Clin Microbiol 1995;33:149-53.
19. Springer B, Stockman L, Teschner K, Roberts GD, Böttger EC. Two-laboratory collaborative study on identification of mycobacteria: Molecular versus phenotypic methods. J Clin Microbiol 1996;34:296-303.
20. Roth A, Reischl U, Streubel A, et al. Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. J Clin Microbiol 2000;38:1094-104.
21. Kirschner P, Springer B, Vogel U, et al. Genotypic identification of mycobacteria by nucleic acid sequence determination: Report of a 2-year experience in a clinical laboratory. J Clin Microbiol 1993;31:2882-9.
22. Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 1959;43:273-90.
23. Runyon EH. Identification of mycobacterial pathogens using colony characteristics. Am J Clin Pathol 1970;54:578-86.
24. Vincent Lévy-Frébault V, Portaels F. Proposed minimal standards for the genus Mycobacterium and for description of new slowly growing Mycobacterium species. Int J Syst Bacteriol 1992;42:315-23.
25. Silcox VA, Good RC, Floyd MM. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol 1981;14:686-91.
26. Wallace RJ Jr, Silcox VA, Tsukamura M, Brown BA, Kilburn JO, Butler WR, et al. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol 1993;31:3231-9.
27. Butler WR, Floyd MM, Silcox V, et al. Standardized Method for HPLC Identification of Mycobacteria. Centers for Disease Control and Prevention. Atlanta (GA): US Department of Health and Human Services; 1996.
28. Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1991;35:773-5.
29. Wilson RW, Steingrube VA, et al. Mycobacterium immunogenum sp. nov., a novel species related to Mycobacterium abscessus and associated with clinical disease, pseudooutbreaks, and contaminated metalworking fluids: An international cooperative study on mycobacterial taxonomy. Int J Syst Evol Microbiol 2001;51:1751-64.
30. Brown BA, Springer B, Steingrube VA, et al. Mycobacterium wolinskyi sp. Nov. and Mycobacterium goodii sp. Nov, two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: A cooperative study from the International Working Group on Mycobacterial Taxonomy. Intern J Syst Bacteriol 1999;49:1493-511.
31. Wallace RJ Jr, Swenson JM, Silcox VA, Good RC. Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei. J Clin Microbiol 1982;16:1003-6.
32. Wallace RJ Jr, O'Brien R, Glassroth J, et al. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990;142:940-53.
33. Swenson JM, Wallace RJ Jr., Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985;28:807-11.
34. Brown BA, Wallace RJ Jr., Onyi GO, De Rosas V, Wallace RJ III. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M chelonae-like organisms. Antimicrob Agents Chemother 1992;36:180-4.
35. American Thoracic Society. Diagnostic standards and classification of tuberculosis and other mycobacterial disease. Am Rev Respir Dis 1980;121:343-58.
36. Ahn CH, McLarty JW, Ahn SS, et al. Diagnositc criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium avium intracellulare. Am Rev Respir Dis 1982;125:388-91.
37. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions. N Engl J Med 1989;321:863-8.
38. Erasmus JJ, McAdams HP, Farrell MA, et al. Pulmonary nontuberculous mycobacterial infection: Radiologic manifestations. Radiographics 1999;19:1487-505.
39. Hartman TE, Swensen SJ, Williams DE. Mycobacterium avium-intracellulare complex: Evaluation with CT. Radiology 1993;187:23-6.
40. Moore EH. Atypical mycobacterial infection in the lung: CT appearance. Radiology 1993;18:777-82.
41. Swensen SJ, Hartman TE, Williams DE. Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis. Chest 1994;105:49-52.
42. Tanaka E, Amitani R, Niimi A, et al. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1997;155:2041-6.